Secondary prevention of ischaemic stroke

doi:10.5316/wjn.v3.i4.97

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8168)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

486

WORD

294

HTML

4815

Figures (1-3)

218

Tables (1-3)

224

Sum=6037

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1023

Download

1108

Sum=2131

Dec 28, 2013 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Neurology

ISSN

2218-6212

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Neurol. Dec 28, 2013; 3(4): 97-114
Published online Dec 28, 2013. doi: 10.5316/wjn.v3.i4.97

Open in New Tab Full Size Figure Download Figure

Figure 1 Medical and surgical treatments which have been proved to be effective for secondary prevention after stroke or transient ischaemic attacks in the last decades. OAC: Oral anticoagulants; CEA: Carotid endarterectomy; AF: Atrial fibrillation.

Open in New Tab Full Size Figure Download Figure

Figure 2 Old and new antiplatelet agents and their mechanism of action. PAR1: Proteinase activated receptor 1; ADP: Adenosine diphosphate; TXA₂: Thromboxane A₂; cAMP: Cyclic adenosine monophosphate; COX₁: Cyclooxygenase-1; 5-HT2A: 5-hydroxytryptamine (serotinin) receptor 2A.

Open in New Tab Full Size Figure Download Figure

Figure 3 Vitamin K antagonist and new anticoagulant mechanism of action. F: Factor.

Citation: Volonghi I, Padovani A, Zotto ED, Giossi A, Costa P, Morotti A, Poli L, Pezzini A. Secondary prevention of ischaemic stroke. World J Neurol 2013; 3(4): 97-114
URL: https://www.wjgnet.com/2218-6212/full/v3/i4/97.htm
DOI: https://dx.doi.org/10.5316/wjn.v3.i4.97